Create Free Account

By creating account you will get access to hot stocks & personalised emails

Cigna Corp

Healthcare US CI

278.195USD
-4.215(1.49%)

Last update at 2024-12-19T18:54:00Z

Day Range

270.22284.68
LowHigh

52 Week Range

284.21369.28
LowHigh

Fundamentals

  • Previous Close 282.41
  • Market Cap88772.53M
  • Volume1934386
  • P/E Ratio30.25
  • Dividend Yield1.76%
  • EBITDA8555.00M
  • Revenue TTM229747.00M
  • Revenue Per Share TTM808.02
  • Gross Profit TTM 22981.00M
  • Diluted EPS TTM10.55

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 8353.00M 6782.00M 10868.00M 6570.00M 3581.00M
Minority interest 78.00M 50.00M 31.00M 41.00M 44.00M
Net income 6668.00M 5365.00M 8458.00M 5104.00M 2637.00M
Selling general administrative 12738.00M 12242.00M 14072.00M 14053.00M 11934.00M
Selling and marketing expenses - - - - -
Gross profit 148436.00M 140710.00M 127867.00M 122924.00M 21041.00M
Reconciled depreciation 2937.00M 2923.00M 2802.00M 3651.00M 695.00M
Ebit 9503.00M 8352.00M 8714.00M -96545.00000M 4070.00M
Ebitda 12440.00M 11275.00M 11516.00M -92894.00000M 4765.00M
Depreciation and amortization 2937.00M 2923.00M 2802.00M 3651.00M 695.00M
Non operating income net other 434.00M -1349.00000M 2566.00M -1684.00000M -498.00000M
Operating income 9503.00M 8352.00M 8714.00M -96545.00000M 4070.00M
Other operating expenses 171668.00M 167490.00M 149709.00M 147173.00M 44988.00M
Interest expense 1228.00M 1208.00M 1438.00M 1682.00M 498.00M
Tax provision 1607.00M 1367.00M 2379.00M 1450.00M 939.00M
Interest income 1228.00M 1208.00M 1438.00M 1682.00M 271.00M
Net interest income -1228.00000M -1208.00000M -1438.00000M -1682.00000M -498.00000M
Extraordinary items - - - 0.00000M 4.00M
Non recurring - - - - -
Other items - - - - -
Income tax expense 1607.00M 1367.00M 2379.00M 1450.00M 935.00M
Total revenue 180642.00M 174272.00M 160577.00M 153743.00M 48569.00M
Total operating expenses 13186.00M -288953.00000M -257509.00000M -250288.00000M 44490.00M
Cost of revenue 32206.00M 33562.00M 32710.00M 30819.00M 27528.00M
Total other income expense net -1150.00000M 121463.00M 107800.00M 103115.00M 5479.00M
Discontinued operations - - - - -
Net income from continuing ops 6668.00M 5415.00M 8489.00M 5120.00M 2646.00M
Net income applicable to common shares 6668.00M 5365.00M 8458.00M 5104.00M 2637.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 152761.00M 143932.00M 154889.00M 155451.00M 155774.00M
Intangible assets 30863.00M 32492.00M 34102.00M 35179.00M 36562.00M
Earning assets - - - - -
Other current assets 6162.00M 2201.00M 12260.00M 2261.00M 11849.00M
Total liab 106410.00M 98981.00M 107705.00M 105065.00M 110395.00M
Total stockholder equity 46223.00M 44872.00M 47112.00M 50321.00M 45338.00M
Deferred long term liab - 7751.00M 8346.00M 8939.00M 9387.00M
Other current liab 37388.00M -10768.00000M -9200.00000M -22199.00000M -21058.00000M
Common stock 4.00M 4.00M 4.00M 4.00M 4.00M
Capital stock 4.00M 4.00M 4.00M 4.00M 4.00M
Retained earnings 41652.00M 37874.00M 32593.00M 28575.00M 20162.00M
Other liab - 29306.00M 33008.00M 39498.00M 37899.00M
Good will 44259.00M 45811.00M 45811.00M 44648.00M 44602.00M
Other assets - 32160.00M 43965.00M 41184.00M 47884.00M
Cash 7822.00M 5924.00M 5081.00M 10182.00M 4619.00M
Cash and equivalents - 5924.00M 5081.00M 10182.00M 4619.00M
Total current liabilities 48716.00M 10768.00M 9200.00M 22199.00M 21058.00M
Current deferred revenue - - - - -
Net debt 23108.00M 25169.00M 28589.00M 22737.00M 32788.00M
Short term debt 2775.00M 2993.00M 2545.00M 3374.00M 5514.00M
Short long term debt 2775.00M 2993.00M 2545.00M 3374.00M 5514.00M
Short long term debt total 30930.00M 31093.00M 33670.00M 32919.00M 37407.00M
Other stockholder equity 6431.00M 8389.00M 15399.00M 22603.00M 26113.00M
Property plant equipment - 4149.00M 3692.00M 4205.00M 4953.00M
Total current assets 37351.00M 28790.00M 26096.00M 28904.00M 21372.00M
Long term investments 925.00M 16288.00M 18438.00M 23262.00M 937.00M
Net tangible assets - -33365.00000M -32801.00000M -29448.00000M -35826.00000M
Short term investments 925.00M 905.00M 920.00M 1331.00M 937.00M
Net receivables 17722.00M 21961.00M 20095.00M 17391.00M 15816.00M
Long term debt 28155.00M 28034.00M 31097.00M 29545.00M 31832.00M
Inventory 5645.00M 4777.00M 3722.00M 3165.00M 2661.00M
Accounts payable 8553.00M 7775.00M 6655.00M 18825.00M 15544.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 13.00M 18.00M 7.00M 6.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1864.00000M -1395.00000M -884.00000M -861.00000M -941.00000M
Additional paid in capital - - - - -
Common stock total equity - 4.00M 4.00M 4.00M 4.00M
Preferred stock total equity - - - - -
Retained earnings total equity - 37874.00M 32593.00M 28575.00M 20162.00M
Treasury stock - -21844.00000M -14175.00000M -6372.00000M -2193.00000M
Accumulated amortization - - - - -
Non currrent assets other 18238.00M -82982.00000M -84828.00000M -85363.00000M -86518.00000M
Deferred long term asset charges - - - - -
Non current assets total 115410.00M 82982.00M 84828.00M 85363.00M 86518.00M
Capital lease obligations - - - - -
Long term debt total - 28100.00M 31125.00M 29545.00M 31893.00M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -5174.00000M -587.00000M -765.00000M -443.00000M -4832.00000M
Change to liabilities - 1865.00M -77.00000M 2187.00M 1918.00M
Total cashflows from investing activities - 3098.00M -3611.00000M 2976.00M -734.00000M
Net borrowings - -500.00000M 800.00M -4796.00000M -5175.00000M
Total cash from financing activities -4294.00000M -11240.00000M -8212.00000M -8533.00000M -7187.00000M
Change to operating activities - 2338.00M 2605.00M 4252.00M -136.00000M
Net income 5164.00M 6746.00M 5415.00M 8489.00M 5120.00M
Change in cash 2361.00M 428.00M -4697.00000M 4834.00M 1556.00M
Begin period cash flow 5976.00M 5548.00M 10245.00M 5411.00M 3855.00M
End period cash flow 8337.00M 5976.00M 5548.00M 10245.00M 5411.00M
Total cash from operating activities 11813.00M 8656.00M 7191.00M 10350.00M 9485.00M
Issuance of capital stock 185.00M 389.00M 326.00M 376.00M 224.00M
Depreciation 3035.00M 2937.00M 2923.00M 2802.00M 3651.00M
Other cashflows from investing activities - 4393.00M -3611.00000M 3419.00M 5148.00M
Dividends paid 1450.00M 1384.00M 1341.00M 15.00M 681.00M
Change to inventory -868.00000M -1055.00000M 143.00M 30.00M 149.00M
Change to account receivables -2202.00000M -2275.00000M -3232.00000M -1266.00000M -990.00000M
Sale purchase of stock -2284.00000M -7607.00000M -7742.00000M -4042.00000M -1987.00000M
Other cashflows from financing activities -469.00000M -2138.00000M 999.00M 1342.00M -252.00000M
Change to netincome - -1647.00000M -225.00000M -4539.00000M -488.00000M
Capital expenditures 1573.00M 1295.00M 1154.00M 1094.00M 1050.00M
Change receivables - -2275.00000M -3232.00000M -1266.00000M -990.00000M
Cash flows other operating - 2085.00M 2027.00M 3181.00M 125.00M
Exchange rate changes - - - - -
Cash and cash equivalents changes - 514.00M -4632.00000M 4793.00M 1564.00M
Change in working capital 3488.00M 620.00M -872.00000M 3598.00M 643.00M
Stock based compensation 286.00M 264.00M 268.00M 289.00M 299.00M
Other non cash items 1499.00M -1431.00000M 141.00M 199.00M 561.00M
Free cash flow 10240.00M 7361.00M 6037.00M 9256.00M 8435.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CI
Cigna Corp		 -4.215 1.49% 278.19 30.25 10.09 0.39 2.10 0.50 -
UNH
UnitedHealth Group Incorporated		 -5.93 1.19% 493.79 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 1.20 0.33% 367.46 18.00 12.66 0.65 2.87 0.74 -
CVS
CVS Health Corp		 -0.82 1.81% 44.46 12.06 9.08 0.29 1.34 0.47 8.96
HUM
Humana Inc		 -5.62 2.34% 234.23 19.16 14.60 0.56 3.37 0.53 -

Reports Covered

Stock Research & News

View All

Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Cigna Corp

900 Cottage Grove Road, Bloomfield, CT, United States, 06002

Key Executives

Name Title Year Born
Mr. David Michael Cordani Pres, CEO & Chair of the Board 1965
Mr. Brian C. Evanko Exec. VP & CFO 1977
Ms. Nicole Susan Jones Exec. VP & Gen. Counsel 1970
Mr. Eric Paul Palmer Pres & CEO of Evernorth 1976
Mr. Paul Sanford Exec. VP of Operations 1968
Ms. Mary Terese Agoglia Hoeltzel CPA Sr. VP of Tax & Chief Accounting Officer NA
Ms. Noelle K. Eder Exec. VP & Global Chief Information Officer 1970
Mr. Ralph Giacobbe Sr. VP & Head of Investor Relations NA
Mr. Everett Neville Exec. VP of Strategy, Corp. Devel. & Solutions 1965
Ms. Cynthia Ryan Exec. VP & Chief HR Officer 1974

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.